Table 1.
The study group’s overall clinical features divided into two main subgroups.
| Causes of CKD | ||||
|---|---|---|---|---|
| non-HD, N = 115 | HD, N = 65 | p * | No (%) | |
| DM and HA (%) | 55 (48) | 18 (28) | >0.05 | 86 (48) |
| Chronic GN (%) | 31 (27) | 18 (28) | >0.05 | 49 (27) |
| ADPKD (%) | 10 (9) | 2 (0) | >0.05 | 12 (6) |
| IN (%) | 5 (4) | 4 (3) | >0.05 | 9 (5) |
| Others (%) | 12 (10) | 12 (18) | >0.05 | 24 (13) |
| Comorbidities ** | ||||
| non-HD, N = 115 | HD, N = 65 | p | All study patients N = 180 | |
| CCI (points) | 6.46 (3.05) | 6.52 (3.21) | >0.05 | 6.48 (3.09) |
| non-HD N = 115 | HD, N = 65 | p * | No (%) | |
| Heart diseases (%) | 74 (64) | 54 (83) | >0.05 | 128 (71) |
| Peripheral vascular disease (%) | 27 (23) | 16 (25) | >0.05 | 43 (23) |
| Cerebrovascular accident (%) | 34 (39) | 21 (32) | >0.05 | 55 (31) |
| Chronic obstructive pulmonary disease (%) | 10 (9) | 6 (9) | >0.05 | 16 (8) |
| Connective tissue disease (%) | 12 (10) | 2 (3) | >0.05 | 14 (8) |
| Gastrointerstitial complications (%) | 16 (14) | 6 (9) | >0.05 | 32 (18) |
| Diabetes mellitus (%) | 39 (34) | 24 (37) | >0.05 | 63 (35) |
| Neoplasmatic disease (%) | 15 (13) | 10 (15) | >0.05 | 25 (14) |
Student’s t-test for independent variables, * chi quadrat test, p-value < 0.05 statistically significant. Abbreviations: DM, diabetes mellitus; GN, glomerulonephritis; IN, interstitial nephritis; CCI, Charlson Comorbidity Index; CKD, chronic kidney disease; HA, hypertension; ADPKD, autosomal dominant polycystic kidney disease; ** Comorbidities were included in groups in the Materials and Methods section.